These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22197181)

  • 1. Factor XIII, clot structure, thrombosis.
    Bagoly Z; Koncz Z; Hársfalvi J; Muszbek L
    Thromb Res; 2012 Mar; 129(3):382-7. PubMed ID: 22197181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII and atherothrombotic diseases.
    Muszbek L; Bereczky Z; Bagoly Z; Shemirani AH; Katona E
    Semin Thromb Hemost; 2010 Feb; 36(1):18-33. PubMed ID: 20391293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin stabilization (factor XIII), fibrin structure and thrombosis.
    Bereczky Z; Katona E; Muszbek L
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):430-7. PubMed ID: 15692256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII Deficiency.
    Karimi M; Bereczky Z; Cohan N; Muszbek L
    Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
    Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
    Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.
    Wartiovaara U; Mikkola H; Szôke G; Haramura G; Kárpáti L; Balogh I; Lassila R; Muszbek L; Palotie A
    Thromb Haemost; 2000 Oct; 84(4):595-600. PubMed ID: 11057856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
    Muszbek L; Bagoly Z; Bereczky Z; Katona E
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):190-205. PubMed ID: 18673233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.
    Shemirani AH; Pongrácz E; Antalfi B; Adány R; Muszbek L
    Thromb Res; 2010 Aug; 126(2):159-62. PubMed ID: 20609463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
    Slowik A; Dziedzic T; Pera J; Figlewicz DA; Szczudlik A
    Cerebrovasc Dis; 2005; 19(3):165-70. PubMed ID: 15644629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
    Ząbczyk M; Natorska J; Undas A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.